Sort
48,018 grants matching “immunotherapy”
A Therapeutic Vaccine for Chronic Hepatitis B
$926,325David R. Milich · Vlp Biotech, Inc. · R44 · FY2012 · AI
Interaction between nuclear epigenetic and metabolic pathways in cancer
$926,251Shelley L Berger · University Of Pennsylvania · R35 · FY2024 · CA
Cytokine Gene Therapy of Cancer - Preclinical Studies
$925,900Walter J Storkus · University Of Pittsburgh At Pittsburgh · P01 · FY2008 · CA
Intracellular Innate Immune Receptors in Cancer Suppression and Immunotherapy
$925,890Jenny P.y. Ting · Univ Of North Carolina Chapel Hill · R35 · FY2019 · CA
Intracellular Innate Immune Receptors in Cancer Suppression and Immunotherapy
$925,890Jenny P.y. Ting · Univ Of North Carolina Chapel Hill · R35 · FY2020 · CA
Intracellular Innate Immune Receptors in Cancer Suppression and Immunotherapy
$925,890Jenny P.y. Ting · Univ Of North Carolina Chapel Hill · R35 · FY2025 · CA
Elucidating and Targeting tumor dependencies and drug resistance determinants at the single cell level
$925,687Andrea Califano · Columbia University Health Sciences · U01 · FY2024 · CA
Development of Small Molecule Inhibitors and Biologic Agents for Treatment of Glioblastoma Using Intracerebral Microdialysis and Signatures of Vulnerability
$925,385Jana Portnow · Beckman Research Institute/City Of Hope · U19 · FY2025 · CA
Role of the microbiota in regulating the mononuclear phagocyte system
$925,047Silvana Goldszmid · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
INTRAVESICAL ONCOLYTIC THERAPY FOR BLADDER CANCER
$924,838Rosa Maria Diaz · Vyriad, Inc. · R44 · FY2018 · CA
Isolation and Distribution of high quality human pancreatic islets
$924,736Ali Naji · University Of Pennsylvania · U42 · FY2008 · RR
Overcoming resistance to anti-PD1 immunotherapy
$924,579Thomas F Gajewski · University Of Chicago · R35 · FY2022 · CA
Microfluidic CAR-T Cell Processing Device
$924,383Tony Ward · Gpb Scientific, Inc. · R42 · FY2019 · CA
Intracellular Innate Immune Receptors in Cancer Suppression and Immunotherapy
$924,309Jenny P.y. Ting · Univ Of North Carolina Chapel Hill · R35 · FY2021 · CA
Humanized PRO 140 for CCR5-Targeted Therapy of HIV
$924,217Progenics Pharmaceuticals, Inc. · R44 · FY2003 · AI
MOUNT SINAI COMMUNITY CLINICAL ONCOLOGY PROGRAM
$924,133Mount Sinai Medical Center (Miami Beach) · U10 · FY2005 · CA
Enhancing Cancer Immunotherapy: Targeting the Tumor and Targeting the Host
$924,071Ronald Levy · Stanford University · R35 · FY2016 · CA
Signal Transduction Events and the Regulation of Cell Growth
$923,994Jane B Trepel · Division Of Clinical Sciences - Nci · ZIC · FY2019 · CA
Administrative Core for SWOG SDMC
$923,959Michael Leo Leblanc · Fred Hutchinson Cancer Center · U10 · FY2024 · CA
Regulation of Lymphocyte Proliferation and Replicative Capacity
$923,719Richard J. Hodes · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Exploring DNA damage response pathways as targets for cancer therapy
$923,400Junjie Chen · University Of Tx Md Anderson Can Ctr · R35 · FY2024 · CA
A Serological Assay for Neutralizing Antitoxin Response in Patients with Clostridioides difficile Infection (Phase II)
$923,175Zhiyong Yang · Fzata, Inc. · R44 · FY2023 · AI
Novel Targets for Vaccine Therapy
$923,127Claudia Palena · Division Of Basic Sciences - Nci · ZIC · FY2011 · CA
A Human Antibody as an Immunotherapy for Cocaine Abuse
$922,721Andrew B Norman · P2d, Inc. · R44 · FY2008 · DA
PEDIATRIC AIDS CLINICAL TRIALS GROUP
$922,683University Of California San Diego · U01 · FY2001 · AI